2012-11-14T06:51:24-06:00 2011-12-31 611436956 NOVAK FRANCELLA LLC ONE PRESIDENTIAL BLVD SUITE 330 BALA CYNWYD PA 19004 990 2011-01-01 412161648 INNOVATIONS IN CANCER THERAPY INNO 2023671165 2025 M STREET NW NO 800 WASHINGTON DC 20036 MICHELLE ZINNERT 2023671165 2012-11-13 LOUIS VERZELLA CPA P00360279 6106689400 2012-11-13 2011 2016-02-24 21:20:13Z MICHELLE ZINNERT 2025 M STREET NW NO 800 WASHINGTON DC 20036 605179 0 X WWW.IO-CENTRAL.ORG. X 2005 MA TO ESTABLISH,NURTURE AND SUPPORT INTERVENTIONAL ONCOLOGY AS THE FOURTH PILLAR OF CANCER THERAPY. 9 9 0 0 0 0 286500 0 282637 604876 11 34 0 269 569148 605179 0 0 0 0 0 0 0 0 0 463013 628121 463013 628121 106135 -22942 262610 261345 0 21677 262610 239668 TO ESTABLISH,NURTURE AND SUPPORT INTERVENTIONAL ONCOLOGY AS THE FOURTH PILLAR OF CANCER THERAPY. 0 0 ANNUAL MEETING - MULTIDISCIPLINARY SCIENTIFIC MEETING, WITH EXHIBITS, ON INTERVENTIONAL ONCOLOGY ISSUES. THE MEETING PRESENTS CURRENT INFORMATION ON RESEARCH, NEW PRODUCTS, AND NEW TECHNIQUES IN THE INTERVENTIONAL ONCOLOGY FIELD. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 0 0 0 0 0 0 0 X 9 9 0 1 0 0 0 0 0 1 1 0 0 0 1 0 0 1 1 0 0 0 X SMITH BUCKLIN & ASSOCIATES INC 2023671100 2025 M STREET SUITE 800 WASHINGTON DC 20036 X MICHAEL C SOULENMD 2.00 X X 0 0 0 GARY S DORFMANMD 1.00 X 0 0 0 RICCARDO A LENCIONIMD 1.00 X 0 0 0 DAVID LUMD 1.00 X 0 0 0 LUIGI SOLBIATIMD 1.00 X 0 0 0 JEFF H GESCHWINDMD 1.00 X 0 0 0 MICHAEL BRUNNERMD 1.00 X 0 0 0 STEPHEN SOLOMONMD 1.00 X 0 0 0 THIERRY DE BAEREMD 1.00 X 0 0 0 0 0 0 0 0 0 0 PRRI INC 500 CUMMINGS CENTER STE 4550 BEVERLY MA 01915 MANAGEMENT 150922 1 ANNUAL MEETING 900099 604876 604876 604876 34 34 MISCELLANEOUS 900099 269 269 269 605179 604876 0 303 12129 475 6000 6062 4577 543550 STRATEGIC PLANNING 45404 BOARD MEETINGS 9924 628121 247051 212588 15559 254 48503 262610 261345 1677 20000 0 0 21677 X 0 0 0 0 262610 239668 262610 239668 262610 261345 -22942 0 X X 1 0 1 X 0 0 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X: MANAGEMENT EVALUATED THE ORGANIZATION'S TAX POSITIONS AND CONCLUDED THAT THE ORGANIZATION HAD MAINTAINED ITS TAX EXEMPT STATUS AND HAD TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE FINANCIAL STATEMENTS. THEREFORE, NO PROVISION OR LIABILITY FOR INCOME TAXES HAS BEEN INCLUDED IN THE FINANCIAL STATEMENTS. AT THE PRESENT TIME, THE ORGANIZATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY U.S. FEDERAL, STATE, OR LOCAL TAX AUTHORITIES FOR YEARS BEFORE 2008. FORM 990, PART VI, SECTION A, LINE 3 SMITHBUCKLIN MAINTAINS THE BOOKS AND RECORDS OF THE ORGANIZATION AND PERFORMS OTHER MANANGEMENT AND ADMINISTRATIVE FUNCTIONS FOR WHICH IT IS COMPENSATED. FORM 990, PART VI, SECTION B, LINE 11 THE 990 IS REVIEWED THE STAFF OF THE MANAGEMENT COMPANY AND IS PROVIDED TO THE TREASURER FOR FINAL REVIEW BEFORE IT IS FILED. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICTS OF INTEREST AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQEST AT OFFICE OF THE MANAGEMENT COMPANY. FORM 990, PART XII, LINE 2C: INOVATIONS IN CANCER THERAPY GOVERNING BODY IS RESPONSIBLE FOR THE FINANCIAL STATEMENT REVIEW AND SELECTION OF THE INDEPENDENT ACCOUNTANT PERFORMING THE REVIEW.